Price $107.93 |
Market Cap
170.99B
|
Sector Health Care |
Div. Growth
8.80%
|
|
P/E
22.0
|
P/B
4.82
|
P/S
3.82
|
Dividend %
1.90%
|
|
P/CF
579.3
|
P/FCF
33.1
|
Op. Cash Flow
10.32M
|
FCF
2.9
|
|
Op. Margin
21.00%
|
Net Margin
17.50%
|
ROE
22.00%
|
ROI
13.50%
|
|
ROA
10.70%
|
EPS Growth
9.90%
|
Current Ratio
1.8
|
Debt/Equity
48.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Psychemedics Corp. (PMD) | $5.72 | - | 4.30% | 36.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.77 | - | - | 105.8M | Strong Buy |
| Greenrose Holding Company Inc (GNRS) | $0.36 | - | - | 18.6M | Strong Buy |
| Great Elm Group Inc (GEG) | $1.95 | - | - | 59.4M | Strong Buy |
| Nutex Health Inc (NUTX) | $1.81 | - | - | 512.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
